Evidence map›Paper›PMID 42754675›Full record

ReviewDermatologie (Heidelberg, Germany)2026

[Focal epithelial hyperplasia-Heck's disease].

Steffi Silling, Ulrike Wieland, Alexander Kreuter

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Steffi SillingNationales Referenzzentrum für Papillom- und Polyomaviren, Institut für Virologie, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Fürst-Pückler-Str. 56, 50935, Köln, Deutschland. steffi.silling@uk-koeln.de.
Ulrike WielandNationales Referenzzentrum für Papillom- und Polyomaviren, Institut für Virologie, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Fürst-Pückler-Str. 56, 50935, Köln, Deutschland.
Alexander KreuterKlinik für Dermatologie, Venerologie und Allergologie, Helios St. Elisabeth Klinik Oberhausen, Universität Witten/Herdecke, Oberhausen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal epithelial hyperplasia (FEH), also known as Heck's disease, is a rare, benign condition of the oral mucosa. It is characterized by multiple, soft, skin-colored or whitish papules or flat nodules that occur primarily on the mucosa of the lips, cheeks, and tongue. The prevalence of this condition is particularly high among indigenous populations of Central and South America, leading to some discussion of a genetic predisposition in addition to familial transmission. However, the number of reported cases from all parts of the world is currently increasing, particularly from Europe. FEH occurs primarily in children and adolescents, but older adults are also affected. Infection with human papillomavirus (HPV) types HPV13 or HPV32 has been identified as the cause of FEH. A definitive diagnosis of Heck's disease based on clinical presentation, histology, and HPV genotyping, as well as the differential diagnosis to rule out other oral manifestations allow for a conservative treatment approach, as the causative HPV types do not have oncogenic potential and the lesions often resolve spontaneously.

Indexed as

Focal Epithelial HyperplasiaMouth MucosaPapillomavirus InfectionsDiagnosis, DifferentialFemaleHuman Papillomavirus VirusesHumansFEHHPV 13HPV 32Oral hyperplasiaSpontaneous regression

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.